Utilidad de la tiroglobulina sérica en el seguimiento del paciente con cáncer diferenciado de tiroides / Thyroglobulin in the follow up of patients with thyroid carcinoma
Rev. chil. endocrinol. diabetes
; 3(3): 197-201, jul. 2010.
Article
en Es
| LILACS
| ID: lil-610323
Biblioteca responsable:
CL1.1
ABSTRACT
Serum thyroglobulin and cervical ultrasonography are the milestones of the follow up of patients with differentiated thyroid carcinoma. When levels of thyroglobulin, stimulated either by discontinuing thyroid hormone supplementation or by using human recombinant TSH are undetectable and cervical ultrasonography is negative for relapse, there is a 99 percent probability that the patient is free of disease. Twenty percent of patients with undetectable thyroglobulin levels under thyroid hormone supplementation, will have levels above 2 ng/ml when treatment is discontinued and in one third of them, a relapse will be detected. Pre ablative thyroglobulin levels below 27.5 ng/mg have a positive predictive value of 98 percent for a disease free survival in low risk patients. Anti thyroglobulin antibodies must be measured along with thyroglobulin value, rendering false negative results. Thyroglobolin determination in the needle washout is useful, when a suspicious cervical lymphadenopathy is aspirated. If this value is twice or highr than that of a simultaneous serum determination, it is suggestive of metastases even with a negative cytology.
Palabras clave
Buscar en Google
Colección:
01-internacional
Base de datos:
LILACS
Asunto principal:
Tiroglobulina
/
Neoplasias de la Tiroides
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
Es
Revista:
Rev. chil. endocrinol. diabetes
/
Revista chilena de endocrinología y diabetes
Asunto de la revista:
ENDOCRINOLOGIA
Año:
2010
Tipo del documento:
Article
País de afiliación:
Chile
Pais de publicación:
Chile